The first set of guidelines has been published for clinicians who wish to prescribe the new drug aducanumab (Aduhelm) and to properly monitor its administration. The recommendations fill the gaps between the FDA’s prescribing information and real-world clinical use, the authors say.
Providers will end 2021 better than they started: report … Early-onset dementia prevalence higher than previously estimated, with Alzheimer’s diagnoses leading the surge … Rare COVID-19 vaccine breakthroughs hit seniors disproportionately … Federal oversight, healthcare fraud prosecutions netted $3.1 billion last fiscal year
Neurologists are very aware of Biogen’s newly approved Alzheimer’s drug, but few have prescribed it so far, a real-time study of the brand’s market launch has found.
The agency is considering whether to establish a national coverage policy for monoclonal antibody drugs that treat Alzheimer’s disease, including the newly approved drug aducanumab (Aduhelm).
The FDA’s new label restricts Aduhelm’s use to Alzheimer’s patients with mild cognitive impairment or mild dementia, drugmaker Biogen announced Thursday.
Greater differences between predicted age based on brain MRI and actual age seen in those with amnestic MCI versus healthy controls
To save itself, Medicare could deny coverage of controversial new Alzheimer’s drug, expert predicts … Aduhelm most appropriate for early dementia, MCI, experts say … Eli Lilly to seek early approval for its Alzheimer’s drug donanemab … Elders’ life expectancy shouldn’t top list of cancer screening priorities: study … Overlooked question on new Alzheimer’s drug: When should patients stop taking it? … Workers at 12 PA nursing homes cite sick time rules as part of vote to strike … NIH studying COVID immunity in vaccinated pregnant women and their infants … Leading clinician groups affirm COVID vaccine safety after heart inflammation findings
Prior to the global pandemic, a Centers for Disease Control and Prevention report indicated that long-term care residents receive only 11 minutes of engagement, with assisted living residents getting just 20 minutes per day (outside of assistance with ADLs and IADLs). As the long-term care and senior living industries emerge from the COVID-19 pandemic and…
New material could remove respiratory droplets from air … New clues point to the origin of Alzheimer’s disease … Advocating reimbursement parity for nurse practitioners … System helped hospital avoid long COVID-19-related lockdowns and saved lives, study says … Advanced age alone should not affect eligibility criteria for heart transplantation, analysis reports … UK to mandate COVID vaccines for nursing homes
Backlash against newly approved Alzheimer’s drug continues with resignations, pharma insiders’ poll calling it a high-priced ‘disaster’ … Latest AARP analysis finds 800 COVID-19 deaths per month in U.S. nursing homes … Newly connected nursing home residents are taking their concerns to public officials … Nation’s veterans homes keeping lax data on COVID outbreaks, especially…
